2-methylthioadenosine 5'-monophosphate has been researched along with Reactive blue 2 in 1 studies
Studies (2-methylthioadenosine 5'-monophosphate) | Trials (2-methylthioadenosine 5'-monophosphate) | Recent Studies (post-2010) (2-methylthioadenosine 5'-monophosphate) | Studies (Reactive blue 2) | Trials (Reactive blue 2) | Recent Studies (post-2010) (Reactive blue 2) |
---|---|---|---|---|---|
6 | 0 | 0 | 10 | 0 | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boeynaems, JM; Communi, D; Gonzalez, NS; Labouret, C; Le Poul, E; Marteau, F; Savi, P | 1 |
1 other study(ies) available for 2-methylthioadenosine 5'-monophosphate and Reactive blue 2
Article | Year |
---|---|
Pharmacological characterization of the human P2Y13 receptor.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Cell Membrane; CHO Cells; Cricetinae; Cyclic AMP; Female; GTP-Binding Protein alpha Subunits, Gi-Go; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Inositol Phosphates; Kinetics; Receptors, Purinergic P2; Thionucleotides | 2003 |